David
Jiménez Castro
Profesor/a Titular Universidad
Universidad Católica San Antonio
Murcia, EspañaPublicaciones en colaboración con investigadores/as de Universidad Católica San Antonio (73)
2024
-
Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry
Archivos de Bronconeumologia, Vol. 60, Núm. 3, pp. 143-152
-
Clinical Presentation and Outcomes of Patients with Cancer-Associated Isolated Distal Deep Vein Thrombosis
Journal of Clinical Oncology, Vol. 42, Núm. 5, pp. 529-537
-
Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism
Journal of Thrombosis and Haemostasis
-
Developmental or Procedural Vena Cava Interruption and Venous Thromboembolism: A Review
Seminars in Thrombosis and Hemostasis
-
Fibrinolytic Agents in Thromboembolic Diseases: Historical Perspectives and Approved Indications
Seminars in Thrombosis and Hemostasis, Vol. 50, Núm. 5, pp. 773-789
-
Obesity a Prognostic Marker in Intermediate-high risk Pulmonary Embolism (PE)? RIETE Registry Review
Thrombosis Update
-
Oxygen Therapy in Patients With Intermediate-Risk Acute Pulmonary Embolism: A Randomized Trial
Chest, Vol. 165, Núm. 3, pp. 673-681
-
Risk of recurrence after discontinuing anticoagulation in patients with COVID-19- associated venous thromboembolism: a prospective multicentre cohort study
eClinicalMedicine, Vol. 73
-
Statin use and mortality in patients with deep vein thrombosis. Data from the RIETE Registry
Thrombosis Research, Vol. 236, pp. 88-96
-
The prognostic value of blood cellular indices in pulmonary embolism
American Journal of Hematology
-
Time to Resolution of Right Ventricle Dysfunction in Patients With Acute Pulmonary Embolism
Archivos de Bronconeumologia, Vol. 60, Núm. 7, pp. 448-450
-
When Direct Oral Anticoagulants Should Not Be Standard Treatment: JACC State-of-the-Art Review
Journal of the American College of Cardiology, Vol. 83, Núm. 3, pp. 444-465
2023
-
A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism
Thrombosis Update, Vol. 13
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Atorvastatin versus Placebo in ICU Patients with COVID-19: Ninety-day Results of the INSPIRATION-S Trial
Thrombosis and haemostasis, Vol. 123, Núm. 7, pp. 723-733
-
COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding
Research and Practice in Thrombosis and Haemostasis, Vol. 7, Núm. 7
-
Cancer-Associated Thrombosis: Trends in Clinical Features, Treatment, and Outcomes From 2001 to 2020
JACC: CardioOncology, Vol. 5, Núm. 6, pp. 758-772
-
Direct Oral Anticoagulants vs Vitamin K Antagonists in Patients With Antiphospholipid Syndromes: Meta-Analysis of Randomized Trials
Journal of the American College of Cardiology, Vol. 81, Núm. 1, pp. 16-30
-
Identification of Low-risk Patients With Acute Symptomatic Pulmonary Embolism
Archivos de Bronconeumologia, Vol. 59, Núm. 9, pp. 575-580
-
Machine learning to predict major bleeding during anticoagulation for venous thromboembolism: possibilities and limitations
British Journal of Haematology, Vol. 201, Núm. 5, pp. 971-981